GXGaosheng Xu

Gaosheng Xu

*This is an algorithmically generated author record based on publicly available information.

Gaosheng Xu has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Hongtian Li

    State Key Laboratory of Female Fertility Promotion, Peking University, Beijing, China

    2 shared publications
  • Hua Ge

    Department of Obstetrics and Gynecology, the First Affiliated Hospital of Baotou Medical School, 41 Linyin Rd., Baotou 014000, China

    2 shared publications
  • Jianmeng Liu

    Institute of Reproductive and Child Health/National Health Commission Key Laboratory of Reproductive Health, School of Public Health, Peking University, Beijing, China

    2 shared publications
  • Li-Xia Yu

    Department of Obstetrics and Gynaecology, Weihai Maternal and Child Health Hospital, 51 Guangming Rd, Weihai 264200, China

    2 shared publications
  • Linxi Chen

    Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical College, University of South China, Hengyang 421001, China

    2 shared publications
  • Man-Xi Bai

    Wyeth Nutrition Science Center, 582 Wuzhong Rd., Shanghai 201103, China

    2 shared publications

Latest Publications

  • miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review)

    by Hongxiang Mu, Wenmao Zhang, Ye Qiu, Ting Tao, Hongliang Wu, Zhuo Chen, Gaosheng Xu

    Breast cancer (BC) is one of the most common malignancies affecting women. BC is a heterogeneous disease that involves multiple oncogenic pathways and/or genetic alterations. MicroRNAs (miRNAs or miRs) are a type of small endogenous single‑stranded RNA that pairs with the 3'untranslated region of target mRNAs to negatively regulate the gene expression of specific mRNA targets. miRNAs are thus involved in various cellular processes, including proliferation, differentiation, apoptosis, migration, metabolism and the stress response. Over the past decade, a number of studies have demonstrated that the expression levels of miRNAs are dysregulated in a number of types of cancer, including BC. In the present review, recent research on miRNAs involved in the occurrence and development of BC, as well as the current findings on miRNAs as potential biomarkers for BC are summarized. In addition, the association between miRNA dysregulation and BC development, and the current status of BC treatment and prognosis are discussed. Finally, several signaling pathways involved in the development of BC and the potential roles of miRNAs in these pathways are reviewed. The present review aims to provide insight into the roles of miRNAs in BC.


  • Mitophagy in cardiovascular disease

    by Hong Zhou, Lu He, Gaosheng Xu, Linxi Chen


  • Essential Role of Nonessential Amino Acid Glutamine in Atherosclerotic Cardiovascular Disease

    by Jinna Chen, Shulei Zhang, Jiaxiong Wu, Shiyuan Wu, Gaosheng Xu, Dangheng Wei

    Atherosclerosis is a major disease that seriously harms human health and is known as the “number one killer” in developed countries and the leading cause of death worldwide. Glutamine is the most abundant nonessential amino acid in the human blood that has multifaceted effects on the body. Recent studies showed that glutamine is negatively corrected with the progression of atherosclerotic lesions. In this review, we focused on the relationship of glutamine with macrophage polarization, nitrification stress, oxidative stress injury, myocardial ischemia–reperfusion injury, and therapeutic angiogenesis to review its roles in atherosclerotic cardiovascular disease.


  • Open Access

    A Correlation Study of DHA Dietary Intake and Plasma, Erythrocyte and Breast Milk DHA Concentrations in Lactating Women from Coastland, Lakeland, and Inland Areas of China

    by Meng-Jiao Liu, Hong-Tian Li, Li-Xia Yu, Gao-Sheng Xu, Hua Ge, Lin-Lin Wang, Ya-Li Zhang, Yu-Bo Zhou, You Li, Man-Xi Bai, et al.

    We aimed to assess the correlation between docosahexaenoic acid (DHA) dietary intake and the plasma, erythrocyte and breast milk DHA concentrations in lactating women residing in the coastland, lakeland and inland areas of China. A total of 408 healthy lactating women (42 ± 7 days postpartum) were recruited from four hospitals located in Weihai (coastland), Yueyang (lakeland) and Baotou (inland) city. The categories of food containing DHA, the average amount consumed per time and the frequency of consumption in the past month were assessed by a tailored DHA food frequency questionnaire, the DHA Intake Evaluation Tool (DIET). DHA dietary intake (mg/day) was calculated according to the Chinese Food Composition Table (Version 2009). In addition, fasting venous blood (5 mL) and breast milk (10 mL) were collected from lactating women. DHA concentrations in plasma, erythrocyte and breast milk were measured using capillary gas chromatography, and were reported as absolute concentration (μg/mL) and relative concentration (weight percent of total fatty acids, wt. %). Spearman correlation coefficients were used to assess the correlation between intakes of DHA and its concentrations in biological specimens. The study showed that the breast milk, plasma and erythrocyte DHA concentrations were positively correlated with DHA dietary intake; corresponding correlation coefficients were 0.36, 0.36 and 0.24 for relative concentration and 0.33, 0.32, and 0.18 for absolute concentration (p < 0.05). The median DHA dietary intake varied significantly across areas (p < 0.05), which was highest in the coastland (24.32 mg/day), followed by lakeland (13.69 mg/day), and lowest in the inland (8.84 mg/day). The overall relative and absolute DHA concentrations in breast milk were 0.36% ± 0.23% and 141.49 ± 107.41 μg/mL; the concentrations were significantly lower in inland women than those from coastland and lakeland. We conclude that DHA dietary intake is positively correlated with DHA concentrations in blood and breast milk in Chinese lactating women, suggesting that the tailored DHA food frequency questionnaire, DIET, is a valid tool for the assessment of DHA dietary intake.


  • Open Access

    DHA in Pregnant and Lactating Women from Coastland, Lakeland, and Inland Areas of China: Results of a DHA Evaluation in Women (DEW) Study

    by You Li, Hong-Tian Li, Leonardo Trasande, Hua Ge, Li-Xia Yu, Gao-Sheng Xu, Man-Xi Bai, Jian-Meng Liu

    Few studies have examined docosahexaenoic acid (DHA) in pregnant and lactating women in developing countries like China, where DHA-enriched supplements are increasingly popular. We aimed to assess the DHA status among Chinese pregnant and lactating women residing areas differing in the availability of aquatic products. In total, 1211 women in mid-pregnancy (17 ± 2 weeks), late pregnancy (39 ± 2 weeks), or lactation (42 ± 7 days) were enrolled from Weihai (coastland), Yueyang (lakeland), and Baotou (inland) city, with approximately 135 women in each participant group by region. DHA concentrations were measured using capillary gas chromatography, and are reported as weight percent of total fatty acids. Mean plasma DHA concentrations were higher in coastland (mid-pregnancy 3.19%, late pregnancy 2.54%, lactation 2.24%) and lakeland women (2.45%, 1.95%, 2.26%) than inland women (2.25%, 1.67%, 1.68%) (p values < 0.001). Similar differences were observed for erythrocyte DHA. We conclude that DHA concentrations of Chinese pregnant and lactating women are higher in coastland and lakeland regions than in inland areas. DHA status in the study population appears to be stronger than populations from other countries studied to date.